Skip to main content

Table 4 Adverse events in 96 cancer patients after the lidocaine patch

From: Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment

Characteristics

Number (%)

Patient No.

96 (100)

Adverse event

 Cold Sensation

6 (6.3)

 Irritation

3 (3.1)

 Itching

3 (3.1)

 Rash

3 (3.1)

 Redness

1 (1.0)